{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:59:42Z","timestamp":1790143182433,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071086"],"award-info":[{"award-number":["81071086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81461130016"],"award-info":[{"award-number":["81461130016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"capital medical development special fund","award":["2011-2013-01"],"award-info":[{"award-number":["2011-2013-01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neulet.2017.04.025","type":"journal-article","created":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T11:45:41Z","timestamp":1492256741000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Effect of risperidone on serum homocysteine levels in first-episode, drug-na\u00efve patients with schizophrenia"],"prefix":"10.1016","volume":"650","author":[{"given":"Ning","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2017.04.025_bib0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/schbul\/sbr034","article-title":"The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis","volume":"37","author":"Uhlhaas","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2017.04.025_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2017.04.025_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fpsyt.2014.00032","article-title":"Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system","volume":"5","author":"Gruber","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2017.04.025_bib0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molmed.2009.10.001","article-title":"One-carbon metabolism and schizophrenia: current challenges and future directions","volume":"15","author":"Krebs","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neulet.2017.04.025_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.psychres.2008.05.009","article-title":"Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: a Chinese Han population-based case-control study","volume":"168","author":"Feng","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0035","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.pnpbp.2007.05.011","article-title":"Plasma homocysteine folate and B12 in chronic schizophrenia","volume":"31","author":"Haidemenos","year":"2007","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0040","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2017.04.025_bib0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":"Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0050","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","article-title":"Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity","volume":"20","author":"Kruman","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2017.04.025_bib0055","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11064-012-0707-3","article-title":"The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients","volume":"37","author":"Dietrich-Muszalska","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0060","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s11064-013-1113-1","article-title":"Homocysteine levels in patients with schizophrenia on clozapine monotherapy","volume":"38","author":"Wysokinski","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0065","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/00048670903001935","article-title":"Homocysteine level in schizophrenia patients","volume":"43","author":"Ma","year":"2009","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.64.1.31","article-title":"Elevated prenatal homocysteine levels as a risk factor for schizophrenia","volume":"64","author":"Brown","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0075","first-page":"5923","article-title":"Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor","volume":"94","author":"Lipton","year":"1997","journal-title":"Neurobiology"},{"key":"10.1016\/j.neulet.2017.04.025_bib0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0085","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevic","year":"2008","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.schres.2007.09.030","article-title":"Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C\/T and 1298A\/C variants","volume":"98","author":"Ellingrod","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajp.2012.03.002","article-title":"Association between MTHFR C677T and A1298C, and MTRR A66G polymorphisms and susceptibility to schizophrenia in a Syrian study cohort","volume":"5","author":"Lajin","year":"2012","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.encep.2010.12.004","article-title":"Hyperhomocysteinemia and schizophrenia: case control study","volume":"37","author":"Mabrouk","year":"2011","journal-title":"L'Encephale"},{"key":"10.1016\/j.neulet.2017.04.025_bib0105","doi-asserted-by":"crossref","first-page":"e004216","DOI":"10.1136\/bmjopen-2013-004216","article-title":"Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine","volume":"4","author":"Tsuda","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.neulet.2017.04.025_bib0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ajcn\/82.3.553","article-title":"A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers1","volume":"82","author":"Verhoef","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neulet.2017.04.025_bib0115","first-page":"772","article-title":"Homocysteine, cobalamin and folate status and their relations to neurocognitive and psychological markers in elderly in northeasten of Iran","volume":"16","author":"Manavifar","year":"2013","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.neulet.2017.04.025_bib0120","first-page":"141","article-title":"Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics","volume":"32","author":"Bicikova","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.neulet.2017.04.025_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11011-014-9534-3","article-title":"Elevated homocysteine level in first-episode schizophrenia patients-the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse","volume":"29","author":"Misiak","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neulet.2017.04.025_bib0130","first-page":"373261","article-title":"Elevated serum levels of homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents","volume":"2012","author":"Kevere","year":"2012","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.neulet.2017.04.025_bib0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpsychires.2009.10.011","article-title":"Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia","volume":"44","author":"Garcia-Miss Mdel","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/mp.2014.66","article-title":"The neurobiology and treatment of first-episode schizophrenia","volume":"20","author":"Kahn","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2017.04.025_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(03)00200-2","article-title":"Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia","volume":"121","author":"Muntjewerff","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.12.006","article-title":"Folate supplementation in schizophrenia: a possible role for MTHFR genotype","volume":"127","author":"Hill","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2017.04.025_bib0155","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/0886022X.2010.504911","article-title":"Role of fenofibrate alone and in combination with telmisartan on renal ischemia\/reperfusion injury","volume":"32","author":"Bhalodia","year":"2010","journal-title":"Ren. Fail."},{"key":"10.1016\/j.neulet.2017.04.025_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2010.08.045","article-title":"Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis","volume":"214","author":"Ntaios","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neulet.2017.04.025_bib0165","first-page":"e5","article-title":"Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents","volume":"17","author":"Cheng","year":"2010","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.neulet.2017.04.025_bib0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2217\/pgs.12.64","article-title":"Association of the MTHFR gene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia","volume":"13","author":"Kuzman","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.neulet.2017.04.025_bib0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0029-1239541","article-title":"Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients","volume":"43","author":"Girardi","year":"2010","journal-title":"Pharmacopsychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017303269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394017303269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T16:38:06Z","timestamp":1569256686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394017303269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":35,"alternative-id":["S0304394017303269"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2017.04.025","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of risperidone on serum homocysteine levels in first-episode, drug-na\u00efve patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2017.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}